Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZL-2306 maintenance therapy in extensive-stage small cell lung cancer
CTR20180888Phase 3Terminated
- Sponsor
- Zai Lab
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of niraparib in small cell lung cancer (SCLC), sponsored by Zai Lab. Started Jun 2018; status: terminated.
02
Drugs
niraparib
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on CTR20180888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180888.